![Maxime Feyeux](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Maxime Feyeux
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
TreeFrog Therapeutics SAS
![]() TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services TreeFrog Therapeutics SAS provides stem cell treatment services. It offers its expertise to patients of heart failure, diabetes, traumatic injury, skin burns, dermatitis, Huntington, and Parkinson disease. The company was founded by Maxime Feyeux, Kevin Alessandri, Jean-Luc Treillou, Erwan Bezard, Laurent Cognet, and Pierre Nassoy and is headquartered in Pessac, France.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Maxime Feyeux
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
MORGAN STANLEY | Investment Managers | Corporate Officer/Principal | |
Deutsche Bank Securities, Inc.
![]() Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Investment Banks/Brokers | Corporate Officer/Principal | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
POXEL | Pharmaceuticals: Major | Director/Board Member | |
Leonard Green & Partners LP
![]() Leonard Green & Partners LP Investment ManagersFinance Leonard Green & Partners LP (Leonard Green & Partners) is a private equity firm founded in 1989 by Leonard I. Green. The firm is headquartered in Los Angeles, California. | Investment Managers | Private Equity Investor | |
PCAS | Chemicals: Major Diversified | Chief Executive Officer | |
Pierre Fabre SA
![]() Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
IRDI Capital Investissement SAS
![]() IRDI Capital Investissement SAS Investment ManagersFinance IRDI Capital Investissement SAS(IRDI Capital) is an independent French regional venture capital/private equity firm which was established in 1981 by Alain Savary. The firm is headquartered in Toulouse. | Investment Managers | Private Equity Investor | |
Citoxlab France SAS
![]() Citoxlab France SAS Miscellaneous Commercial ServicesCommercial Services Citoxlab France SAS operates as a research laboratory. It offers services in toxicology, genomics, pharmacology, pharmacokinetics, bio-analysis, ecotoxicology, stability testing and regulatory affairs. The company was founded in 1969 and is headquartered in Miserey, France. | Miscellaneous Commercial Services | Director/Board Member | |
Exane SA (Broker)
![]() Exane SA (Broker) Investment Banks/BrokersFinance Exane SA (Broker) (Exane) is the brokerage division of Exane SA, itself a subsidiary of Verner Investissements SAS in France. Established in 2004 as a joint venture between BNP Paribas and Verner Investissements, the firm is based in Paris and specializes in European equity research and broking activities. Exane has research centers in Paris and London which are supported by a team of economists and strategists. | Investment Banks/Brokers | Analyst-Equity | |
Virginia Polytechnic Institute & State University | College/University | Undergraduate Degree | |
CELLECTIS S.A. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PALUMED SA
![]() PALUMED SA Pharmaceuticals: MajorHealth Technology PALUMED SA develops and produces pharmaceutical products for the treatment of Alzheimer's disease. The firm specializes in the development and production of new antimalarial agents and antibacterial molecules. The company was founded on December 8, 2000 and is headquartered in Castanet-Tolosan, France. | Pharmaceuticals: Major | Director/Board Member | |
GENFIT | Pharmaceuticals: Major | Director/Board Member | |
The Rockefeller University | College/University | Doctorate Degree | |
Université de Bordeaux | College/University | Doctorate Degree | |
EM Lyon Business School | College/University | Undergraduate Degree | |
IXO Private Equity SAS
![]() IXO Private Equity SAS Investment ManagersFinance IXO Private Equity SAS (IXO-PE) is an independent France-based regional private equity firm which was founded in 2002. Headquartered in Toulouse with an office in Bordeaux, the firm was previously known as ICSO Gestion. Their culture emphasizes regional development and local employment creation. The firm manages FCPR limited partnership venture capital funds for institutions and FIP regional development funds for individual investors. IXO-PE's institutional clients include local collectivities, insurance companies and international corporations as well as regional, national and European banks. | Investment Managers | Private Equity Investor | |
Ecole Polytechnique | College/University | Undergraduate Degree | |
BPIFrance Investissement SAS
![]() BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor | |
TXCELL | Miscellaneous Commercial Services | Director/Board Member | |
VOLUNTIS S.A. | Packaged Software | Director/Board Member | |
Laboratoire GlaxoSmithKline SAS
![]() Laboratoire GlaxoSmithKline SAS Pharmaceuticals: MajorHealth Technology Laboratoire Glaxosmithkline SAS manufactures pharmaceutical products. The company was founded in 2001 and is headquartered in Rueil-Malmaison, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CU CHEMIE UETIKON GmbH
![]() CU CHEMIE UETIKON GmbH Chemicals: SpecialtyProcess Industries CU CHEMIE UETIKON GmbH engages in the production and development of active ingredients, pharmaceutical intermediates, as well as specialty chemicals for the chemical, pharmaceutical, and electronics industries. The company was founded on November 5, 1991 and is headquartered in Lahr, Germany. | Chemicals: Specialty | Chief Executive Officer | |
College de France | College/University | Doctorate Degree | |
BIOM'UP | Medical Specialties | Director/Board Member | |
YSOPIA Biosciences SA
![]() YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Biotechnology | Chief Executive Officer | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
CATALENT, INC. | Pharmaceuticals: Major | Director/Board Member | |
NEOMA Business School | College/University | Masters Business Admin | |
ffly4u SAS
![]() ffly4u SAS Specialty TelecommunicationsCommunications Ffly4u SASU provides a low frequency localization services for mobile assets. It also offers services like movement, temperature, noise or opening detection in order to guarantee the integrity of sensitive assets. The company was founded by Pages Olivier in 2015 and is headquartered in Toulouse, France. | Specialty Telecommunications | Director/Board Member | |
ENYO Pharma SA
![]() ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Corporate Officer/Principal | |
Bionest Partners SAS
![]() Bionest Partners SAS Miscellaneous Commercial ServicesCommercial Services Bionest Partners SAS operates as a global consulting firm which focuses on pharma, biotech, medical device and diagnostics. It offers strategy development, product planning and assessment services. The company was founded by Robert J. Easton and Alain J. Gilbert and is headquartered in Paris, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Owkin France SASU
![]() Owkin France SASU Medical/Nursing ServicesHealth Services Owkin France SAS provides artificial intelligence for predictive medicine. The company was founded on September 7, 2016 and is headquartered in Paris, France. | Medical/Nursing Services | Director/Board Member | |
Dynacure SA
![]() Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Director/Board Member | |
DNA Script SAS
![]() DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Backbone SAS
![]() Backbone SAS Medical SpecialtiesHealth Technology Backbone SAS is a venture capital and private equity firm. It specializes in investments in late venture companies, startups, buyouts, growth financing, leveraged buyouts, and buyins. The company was founded by Nazanine Sahami on March 25, 2015 and is headquartered in Le Bouscat, France. | Medical Specialties | Director/Board Member | |
MicroPEP Technologies SAS
![]() MicroPEP Technologies SAS Miscellaneous Commercial ServicesCommercial Services MicroPEP Technologies SAS engages in the development of biomimetic peptides that manage plant genetics. The company was founded by Thomas Laurent on April 15, 2016 and is headquartered in Toulouse, France. | Miscellaneous Commercial Services | Director/Board Member | |
Bionest Partners Finance SAS | Corporate Officer/Principal | ||
Orano Med SAS
![]() Orano Med SAS BiotechnologyHealth Technology Orano Med SAS is a French biotechnology company that utilizes nuclear technology to develop new therapies for cancer patients with resistant forms of cancer. The company is based in Châtillon, France, and the CEO of the company is Julien Dodet. The company specializes in targeted alpha therapy treatments, which combines biological molecules to target cancer cells with the properties of lead-212 (212pb) to destroy them while limiting the impact on surrounding healthy cells. Orano Med has formed collaborations with prestigious institutions and biopharmaceutical companies to develop several treatments using 212pb combined with various targeting agents. The company has 212pb manufacturing facilities, laboratories, and R&D centers in France and the United States and is currently investing to expand its GMP-manufacturing capacities for 212pb radiolabeled pharmaceuticals. Orano Med is ultimately controlled by the Government of France. | Biotechnology | Director/Board Member | |
GeneSpire Srl
![]() GeneSpire Srl BiotechnologyHealth Technology GeneSpire Srl is a holding company, which engages in the development of transformative gene therapies for patients with genetic diseases. The company was founded by Luigi Naldini and Alessio Cantone in March 2020 and is headquartered in Milan, Italy. | Biotechnology | Chief Executive Officer | |
Epsilen Bio Srl
![]() Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Epsilen Bio SRL operates as a biotechnology company. It develops novel therapies based on epigenetic silencing. The company was founded by Angelo Lombardo and Luigi Naldini in December 2019 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Chief Executive Officer | |
Swallis Medical SAS
![]() Swallis Medical SAS Miscellaneous Commercial ServicesCommercial Services Swallis Medical SAS engages in the provision of diagnostic and monitoring solutions for problem of swallowing disorders. The company was founded by Linda Nicolini in 2019 and is headquartered in Toulouse, France. | Miscellaneous Commercial Services | Director/Board Member | |
WCG CLINICAL, INC. | Biotechnology | Director/Board Member | |
APSI 3D SAS | Director/Board Member |
Statistik
International
Frankreich | 40 |
Vereinigte Staaten | 9 |
Italien | 3 |
Deutschland | 2 |
Sektoral
Health Technology | 20 |
Finance | 10 |
Consumer Services | 10 |
Commercial Services | 6 |
Process Industries | 3 |
Operativ
Director/Board Member | 39 |
Corporate Officer/Principal | 13 |
Chief Executive Officer | 7 |
Independent Dir/Board Member | 5 |
Undergraduate Degree | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Maxime Feyeux
- Unternehmensverbindungen